Showing results (2001-2010 of 2,268) with videos related to
Sort By:
Pageof 227
Hypertension (Dallas, Tex. : 1979)|March 25, 2026
Sex Differences in Cardiac Remodeling and Dysfunction in Primary AldosteronismYu-Ching Chang, Chi-Sheng Hung, Zheng-Wei Chen, et al.Human Molecular Genetics|July 30, 2010
Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gammaMing-Chang Chiang, Chiung-Mei Chen, Maw-Rong Lee, et al.Research Square|May 20, 2021
Virtual Versus In-Person Surgical Fellowship Interviews and Ranking Variability: the COVID-19 ExperienceTa Chen Chang, Elizabeth A Hodapp, Richard K Parrish, et al.Oncology Reports|January 19, 2024
Aberrant trophoblastic differentiation in human cancer: An emerging novel therapeutic target (Review)Chen Chang, Yi-Lin Chen, Yi-Wen Wang, et al.Journal of Cellular Physiology|January 7, 2012
The effect of exogenous histone H1 on rat adipose-derived stem cell proliferation, migration, and osteogenic differentiation in vitroLi-Wen Hsu, Shigeru Goto, Toshiaki Nakano, et al.Journal of Ophthalmology|April 25, 2022
The Effect of Changing Fellowship Interview Format on Candidate Ranking Variabilities: The COVID-19 ExperienceTa Chen Chang, Elizabeth A Hodapp, Richard K Parrish, et al.International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomographyJoseph Tung-Chieh Chang, Sheng-Chieh Chan, Tzu-Chen Yen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathologyTzu-Chen Yen, Joseph Tung-Chieh Chang, Shu-Hang Ng, et al.Frontiers in Genetics|June 12, 2024
Molecular epidemiology of dengue in Malaysia: 2015-2021Yu Kie Chem, Surya Pavan Yenamandra, Chee Keong Chong, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 4, 2023
Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 MutationsAlessandra Bearz, Jean-François Martini, Jacek Jassem, et al.Pageof 227